预防新发性心力衰竭:在A阶段进行干预
Bharathi Upadhya1, Shriram Hegde2, Manasi Tannu1
1Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
American journal of preventive cardiology
|October 25, 2023
概括
在A期心力衰竭 (HF) 患者中预防心力衰竭需要早期意识到风险因素并改变生活方式. 包括管理血压,糖尿病和脂质在内的综合策略对于原始HF预防至关重要.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 预防医学 预防医学
背景情况:
- 预防心力衰竭 (HF) 是一个关键的公共卫生问题.
- 一阶段的HF患者没有症状,但面临HF发展风险.
- 目前针对A期患者的检测策略不足.
研究的目的:
- 突出了对预防甲阶段HF综合策略的需要.
- 强调早期风险因素识别和干预.
- 倡导原始和初级的HF预防策略.
主要方法:
- 审查当前的HF预防指南和风险因素.
- 确定A阶段HF患者的异质性和风险分层需求.
- 讨论包括生活方式和医疗管理在内的全面预防策略.
主要成果:
- 阶段A患者是多样化的,具有不同的HF风险.
- 密集的血压,血糖和脂质管理是关键.
- 心脏健康的行为 (生命的基本8) 是至关重要的.
- 非传统的风险因素 (例如,CKD,AFib,遗传易感性) 会增加HF风险.
- 生物标志物,成像和心声回声学可以提高风险预测.
结论:
- 公众对高频风险因素的认识和早期健康的生活方式的选择至关重要.
- 识别高频风险增加因素对于早期干预至关重要.
- 政策必须超越二次预防,包括原始和初级HF预防.
相关概念视频
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Heart Failure IV: Classification and Diagnostic Evaluation
18
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18
Mitral Regurgitation IV: Nursing Management
40
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
40


